Glipizide
Product Images NDC 50436-0141

2 FDA label images from Unit Dose Services · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 50436-0141). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glipizide-structure.jpg (Glipizide Structure)

Glipizide-structure.jpg (Glipizide Structure)
Chemical structure of Glipizide showing its molecular configuration with various rings and functional groups as presented in the image.*
FDA Label Image

Label Image (Lbl504360141)

Label Image (Lbl504360141)
Glipizide 5 mg tablets carton containing 30 tablets labeled under NDC 50436-0141 by Unit Dose Services. The label includes manufacturer details for Apotex Inc., Toronto, Canada, and displays storage instructions to keep at 20-25°C (68-77°F) in a tight, light-resistant container. Multiple repetitions of the NDC, drug name, strength, lot, and expiration placeholders appear on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.